Search

Issue
Title
Authors
Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII
Dincel E.D., Kuran E.D., Ece A., Basoglu-Unal F., Renzi G., Badii G., Carta F., Supuran C.T., Ulusoy-Guzeldemirci N.
Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands
Atapour-Mashhad H., Soukhtanloo M., Golmohammadzadeh S., Chamani J., Nejabat M., Hadizadeh F.
A Systematic Quantitative Approach to Rational Drug Design and the Discovery of Novel Human Antigen R (HuR) Inhibitors
Dey J., Kaushiki K., Mishra K.A., Sudheer P., Sethi K.K.
Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents
Walhekar V., Bagul C., Kumar D., Achaiah G., Muthal A., Kulkarni R., Basavarju M.
How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Root-Bernstein R.
Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins
V. Golovina G., N. Rychkov G., A. Ol'shevskaya V., V. Zaitsev A., N. Kalinin V., A. Kuzmin V., A. Shtil A.
Chemoprevention of Breast Cancer by Dietary Compounds
S. Vadodkar A., Suman S., Lakshmanaswamy R., Damodaran C.
In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer
Alamri A., Alkhilaiwi F., Khan N., Tasleem M.
A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB
Castelli S., Katkar P., Vassallo O., Falconi M., Linder S., Desideri A.
DNA Binding and Anticancer Activity of Novel Cyclometalated Platinum (II) Complexes
Nabavizadeh S., Rashidi M., Mohammadi R., Yousefi R., Aseman M.
Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Bozec A., Peyrade F., Milano G.
Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma
B. Nambotin S., R. Wands J., Kim M.
Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies
Dhawale S., Dabhade P., Mokale S.
Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and In silico Studies
Trawally M., Demir-Yazıcı K., Angeli A., Kaya K., Akdemir A., Supuran C., Güzel-Akdemir Ö.
Green Synthesis of a Novel Phytoalexin Derivative: In Silico Profiling, Apoptotic Induction, and Antiproliferative Activity against MCF-7 cells - From Vineyards to Potent Anticancer Drug Molecule
Roy L.D., Kumar J.
New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin
Moreau P., Dezhenkova L., Anizon F., Nauton L., Thery V., Liang S., Kaluzhny D., Shtil A.
Conventional Chemotherapy and Emerging Targeted Therapy for Advanced Adrenocortical Carcinoma
Xu Y., Zhu Y.
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors
C. Nair P.
Identification of Flavonoid-based Hypoxia-inducible Factor-2 Alpha Inhibitors for the Treatment of Breast Cancer– In silico and In vitro Evidence
Shahinaz , Baba M., Gor R., Ramamurthy C., Mohideen H., Ramalingam S., Vijayakumar T.
Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid Leukemia Based on Integrating Network Pharmacology and Molecular Docking
Li H., Jing Y., Chai Y., Sun X., He X., Xue S., Xi Y., Ma X.
JHD205, A Novel Abemaciclib Derivative, Exerts Antitumor Effects on Breast Cancer by CDK4/6
Ji J., Qin J., Wang X., Lv M., Hou X., Jing A., Zhou J., Zuo L., Liu W., Feng J., Qian Q., Liu Y., Wang X., Liu B.
Anti-cancer Glycosidase Inhibitors from Natural Products: A Computational and Molecular Modelling Perspective
Singh A., Mhlongo N., Soliman M.
Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family
Christodoulou M., Kontos C., Halabalaki M., Skaltsounis A., Scorilas A.
UGT1A1 Gene Polymorphisms and the Toxicities of FOLFIRI in Chinese Han Patients with Gastrointestinal Cancer
Zhou C., Ma T., Su Y., Ye Z., Ji J., Yu Y., Zhang J., Liu B., Zhu Z.
Screening and in vitro Biological Evaluation of Novel Multiple Tyrosine Kinases Inhibitors as Promising Anticancer Agents
Li X., Ruan P., Jiang G., Zhang W.
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment
Rani M., Sharma A., Nischal A., Khattri S., Sahoo G., Singh R.
Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist
Niranjan V., R V., Philip S., Uttarkar A., Kusanur R., Kumar J.
Anti-lung Cancer Activity of Synthesized Substituted 1,4-Benzothiazines: An Insight from Molecular Docking and Experimental Studies
Amin A., Zubaid-Ul-Khazir , Ji A., Bhat B., Murtaza D., Hurrah A., Bhat I., Parveen S., Nisar S., Sharma P.K.
Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy
Devi K., Rajavel T., Russo G., Daglia M., Nabavi S., Nabavi S.
Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Kontos C., Christodoulou M., Scorilas A.
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents
A. Toropov A., P. Toropova A., Benfenati E., Gini G., Leszczynska D., Leszczynski J.
An Updated Review on Dysregulated lncRNAs and their Contribution to the Various Molecular Types of Lung Carcinoma
Dastmalchi N., Alipour M., Safaralizadeh R., Hajiasgharzadeh K.
Design, Synthesis, and Molecular Docking Studies of Indolo[3,2-c]Quinolines as Topoisomerase Inhibitors
Badr M., Elmongy E., Sayed I., Moemen Y., Khalil A., Elkhateeb D., Binsuwaidan R., Ali H.
VEGFR2 Mimicking Peptide Inhibits the Proliferation of Human Umbilical Vein Endothelial Cells (Huvecs) by Blocking VEGF
Ghasemali S., Barzegar A., Farajnia S., Rahmati M., Negahdari B., Etemadi A., Nazari A.
Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results
Baysal Ö., Genç D., Silme R.S., Kırboğa K.K., Çoban D., Ghafoor N.A., Tekin L., Bulut O.
Molecular Treatment of Different Breast Cancers
Wang Y., Cao S., Chen Y.
Natural Flora and Anticancer Regime: Milestones and Roadmap
Bhatnagar I., Thomas N., Kim S.
Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging
Melendez-Alafort L., Carlo Muzzio P., Rosato A.
Novel Quinoline Nitrate Derivatives: Synthesis, Characterization, and Evaluation of their Anticancer Activity with a Focus on Molecular Docking and NO Release
Thanneeru V., Panigrahi N.
Assessment of Cytotoxic/Antitumour Potential and in silico Study of Salazinic Acid Isolated from Parmotrema concurrens
da Conceição de Lira M., da Silva M., Rocha T., de Moura D., Santos Costa E., dos Santos Maia M., Scotti L., Scotti M., de Lourdes Lacerda Buril M., Pereira E., de Aguiar Júnior F.C., de Britto Lira Nogueira M., da Silva Santos N., da Silva Falcão E., de Melo S.
Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunits p50 and p65: A Molecular Docking and Molecular Dynamics Study
Khan A., Singh D., Waidha K., Sisodiya S., Gopinath P., Hussian S., Tanwar P., Katare D.
Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma
Yao M., Wang L., Qiu L., Qian Q., Yao D.
Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives
Papaioannou M., Soderholm A.A., Hong W., Dai Y., Roediger J., Roell D., Thiele M., Nyronen T.H., Baniahmad A.
Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
Coderch C., Morreale A., Gago F.
PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes
Tuncbilek Z., Cakmak N., Tas A., Ayan D., Silig Y.
Imidazole and Biphenyl Derivatives as Anti-cancer Agents for Glioma Therapeutics: Computational Drug Repurposing Strategy
Murali P., Karuppasamy R.
In-silico Evaluation of Novel Honokiol Derivatives against Breast Cancer Target Protein LKB1
Shahid I., Shoaib M., Raza R., Jahangir M., Abbasi S., Riasat A., Akbar A., Mehnaz S.
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer
Santos M., de Azevedo Teotônio Cavalcanti M., de Medeiros e Silva Y.M., dos Santos Nascimento I., de Moura R.
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors
Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.
Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents
Planche A.S., Kleandrova V.V., Luan F., Cordeiro M.N.
Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment
Jiaguo H., Zhiguo L., Wenbin Z.
In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers
Cordova-Bahena L., Landero-Marin C., Flores-Hernandez X., Alvarez-Coronel L., Jimenez-Uribe A., Salinas-Jazmin N., An Z., Velasco-Velazquez M.
QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma
Wang M., Qiu B., Wang W., Li X., Huo H.
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms
Sethi A., Munagalasetty S., Arifuddin M., Carradori S., Supuran C., Alvala R., Alvala M.
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab)
Fernández M., Reyes A.L., Paolino A., Savio E., Cerecetto H., Cabral P., Gambini J., Camacho X., Perroni C., Alfaya L., Cabrera M., Tassano M., García M.
1 - 55 of 55 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"